United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - bicalutamide (unii: a0z3nau9dp) (bicalutamide - unii:a0z3nau9dp) - bicalutamide 50 mg - casodex 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (lhrh) analog for the treatment of stage d2 metastatic carcinoma of the prostate. casodex 150 mg daily is not approved for use alone or with other treatments [see clinical studies (14.2)]. casodex is contraindicated in: casodex is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet’s components. hypersensitivity reactions including angioneurotic edema and urticaria have been reported. casodex has no indication for women, and should not be used in this population. casodex can cause fetal harm when administered to a pregnant woman [see use in specific populations (8.1)] . risk summary casodex is contraindicated for use in pregnant women because it can cause fetal harm. casodex is not indicated for use in females. there are no human data on the use of casodex in pregnant women. in animal reproduction studies, oral administration of bicalutamide to p

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pliva pharma ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - bicalutamide - oral tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - bicalutamide - oral tablet - 150mg